SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001655759-24-000033
Filing Date
2024-03-18
Accepted
2024-03-18 16:45:12
Documents
13
Period of Report
2024-03-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20240314.htm   iXBRL 8-K 28028
  Complete submission text file 0001655759-24-000033.txt   157382

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20240314.xsd EX-101.SCH 1901
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20240314_lab.xml EX-101.LAB 23451
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20240314_pre.xml EX-101.PRE 13581
16 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20240314_htm.xml XML 2816
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 24759708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)